QUOTE AND NEWS
SeekingAlpha  Aug 20  Comment 
By SA Transcripts: Astro-Med, Inc. (NASDAQ:ALOT) Q2 2015 Results Earnings Conference Call August 20, 2014, 09:00 AM ET Executives David Calusdian - Investor Relations, Sharon Merrill Greg Woods - President and CEO Joe O'Connell -...
DailyFinance  May 22  Comment 
Astro-Med, Inc. (NASDAQ: ALOT), a leading manufacturer of specialty high-tech printing systems and data acquisition products, today reported net sales of $20.8 million for the three months ended May 3, 2014, an increase of...
SeekingAlpha  Mar 19  Comment 
Astro - Med, Inc. (ALOT) Q4 2014 Results Earnings Conference Call March 19, 2013, 11:00 AM ET Executives David Calusdian - Investor Relations, Sharon Merrill Greg Woods - President and CEO Joe O'Connell - CFO Analysts Anya...
StreetInsider.com  Mar 18  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Astro-Med%2C+Inc.+%28ALOT%29+Tops+Q4+EPS+by+1c/9293867.html for the full story.
DailyFinance  Mar 10  Comment 
WEST WARWICK, RI -- (Marketwired) -- 03/10/14 -- Astro-Med, Inc. (NASDAQ: ALOT) announced today that the Company has rescheduled the date for its 2014 Annual Meeting of Shareholders. The Annual Shareholders' Meeting will be held on...
DailyFinance  Mar 4  Comment 
WEST WARWICK, RI -- (Marketwired) -- 03/04/14 -- Astro-Med, Inc. (NASDAQ: ALOT), a manufacturer of specialty high tech printing and data acquisition products, will announce its financial results for the Fourth Quarter and the Fiscal Year ended...
DailyFinance  Feb 12  Comment 
WEST WARWICK, RI -- (Marketwired) -- 02/12/14 -- Astro-Med, Inc. (NASDAQ: ALOT), a leading provider of advanced technology printing and data acquisition systems, announced that the acquisition of Miltope Corporation's line of ruggedized aerospace...
SeekingAlpha  Jan 14  Comment 
By Kingmaker: With all the looming doubts about whether the stock market can continue its historic run, investors may want to consider under the radar investments that are still massively undervalued compared to their potential. One company that...
DailyFinance  Jan 13  Comment 
WEST WARWICK, RI, and HOPE HULL, AL -- (Marketwired) -- 01/13/14 -- Astro-Med, Inc. (NASDAQ: ALOT), and Miltope Corporation, d/b/a VT Miltope, a company of VT Systems, today announced that the companies have entered into a definitive...
DailyFinance  Dec 18  Comment 
Inuvo, Inc. (NYSE MKT: INUV) (the "Company" or "Inuvo"), an Internet marketing and technology company that delivers targeted advertisements into websites and applications reaching desktop and mobile devices, today announced...




 
TOP CONTRIBUTORS

Astro-Med, Inc. (Astro-Med) designs, develops, manufactures and distributes a range of specialty printers and data acquisition and analysis systems, including both hardware and software. The company's primary foci are avionics and medical equipment - sleep equipment in particular.[1] Although most of the products that Astro-Med makes are not consumer products, the company must go through the long and difficult process of having its products approved by the Federal Aviation Authority (FAA) or the Food and Drug Administration (FDA). This is a source of uncertainty and concern throughout the healthcare and aviation industry.

Business Growth

Since healthcare products are bought out of necessity rather than luxury, the healthcare products industry is less susceptible to recessions such as the 2008 Financial Crisis. However, the industry is subject to the rapid rise in demand following recessions. However, aviation products are more susceptible to fluctuations in demand. The combination of these two factors have caused a dip in 2009 revenues and a subsequent 10% increase in revenue. [2]

Key Trends and Forces

Product Development

Developing a new product is a time-consuming and costly endeavor. For healthcare products, hundreds of thousands of designs and prototypes must be screened to identify a handful of potential successes. Even fewer of these candidates are found to be acceptably effective at identifying a disease. The equipment must then pass strict safety standards in several series of clinical trials. Throughout this process, any number of failures can occur. In particular, if the FDA disapproves a certain product, the company's stock may plummet immediately since the Research and Development Expense might have potentially have 0% return on investment or even cause substantial losses.

Health insurance

Changes in health care coverage may impact sales. If an insurance program changes its policies and removes coverage for a certain treatment, less patients will elect to obtain treatment, reducing demand for healthcare equipment and reducing sales for Astro-Med. In general, insurance programs are more likely to cover essential expenses, such as heart disease medication, and less likely to cover nonessential expenses, such as sleep disorders.

Competition

Astro-Med's competition stems more from its aviation side than its healthcare products side. On the aviation side, the company competes with the big industrial names such as Boeing Company (BA). The aviation industry is fiercely competitive, and this is no exception. In its healthcare products side, Astro-Med has a niche segment of the market. Most of the competition is from smaller companies such as Natus Medical (BABY) and Welch Allyn. However, JOHNSON & JOHNSON (JNJ) is a major competitor that has released products covering all of the niche markets smaller companies cover.






References

  1. Reuters: Company Profile - ALOT
  2. Wikinvest SEC Files: ALOT 2010 10-K, Item 8
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki